$BHVN Biohaven Pharmaceutical Holding Co Ltd. Insider Trading Week 50/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Biohaven Pharmaceutical Holding Co Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Biohaven Pharmaceutical Holding Co Ltd. in week 50/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Special Projects & ... | Option Exercise | M | 0.00 | 625 | 0 | 1,875 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Special Projects & ... | Payment of Exercise | F | 52.13 | 284 | 14,805 | 341 | 625 to 341 (-45.44 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Special Projects & ... | Buy | M | 0.00 | 625 | 0 | 625 | 0 to 625 |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | M | 0.00 | 3,000 | 0 | 9,000 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Payment of Exercise | F | 52.13 | 1,361 | 70,949 | 5,639 | 7 K to 5.6 K (-19.44 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Buy | M | 0.00 | 3,000 | 0 | 7,000 | 4 K to 7 K (+75.00 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 52.13 | 15,000 | 781,950 | 15,000 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,375 | 0 | 10,125 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Payment of Exercise | F | 52.13 | 1,531 | 79,811 | 1,844 | 3.4 K to 1.8 K (-45.36 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 0.00 | 3,375 | 0 | 3,375 | 0 to 3.4 K |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Payment of Exercise | F | 52.13 | 480 | 25,022 | 770 | 1.3 K to 770 (-38.40 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Buy | M | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | M | 0.00 | 3,000 | 0 | 9,000 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Payment of Exercise | F | 52.13 | 1,245 | 64,902 | 1,755 | 3 K to 1.8 K (-41.50 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Buy | M | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Payment of Exercise | F | 52.13 | 1,701 | 88,673 | 2,049 | 3.8 K to 2 K (-45.36 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Buy | M | 0.00 | 3,750 | 0 | 3,750 | 0 to 3.8 K |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Option Exercise | A | 52.13 | 12,000 | 625,560 | 12,000 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,700 | 0 | 11,100 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Payment of Exercise | F | 52.13 | 1,678 | 87,474 | 4,522 | 6.2 K to 4.5 K (-27.06 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Buy | M | 0.00 | 3,700 | 0 | 6,200 | 2.5 K to 6.2 K (+148.00 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | M | 0.00 | 10,950 | 0 | 32,850 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Payment of Exercise | F | 52.13 | 4,965 | 258,825 | 5,985 | 11 K to 6 K (-45.34 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Buy | M | 0.00 | 10,950 | 0 | 10,950 | 0 to 11 K |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Special Projects & ... | Option Exercise | M | 0.00 | 625 | 0 | 1,875 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Special Projects & ... | Payment of Exercise | F | 52.13 | 284 | 14,805 | 341 | 625 to 341 (-45.44 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Special Projects & ... | Buy | M | 0.00 | 625 | 0 | 625 | 0 to 625 |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | M | 0.00 | 3,000 | 0 | 9,000 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Payment of Exercise | F | 52.13 | 1,361 | 70,949 | 5,639 | 7 K to 5.6 K (-19.44 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Buy | M | 0.00 | 3,000 | 0 | 7,000 | 4 K to 7 K (+75.00 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 52.13 | 15,000 | 781,950 | 15,000 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,375 | 0 | 10,125 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Payment of Exercise | F | 52.13 | 1,531 | 79,811 | 1,844 | 3.4 K to 1.8 K (-45.36 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 0.00 | 3,375 | 0 | 3,375 | 0 to 3.4 K |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Payment of Exercise | F | 52.13 | 480 | 25,022 | 770 | 1.3 K to 770 (-38.40 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Buy | M | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | M | 0.00 | 3,000 | 0 | 9,000 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Payment of Exercise | F | 52.13 | 1,245 | 64,902 | 1,755 | 3 K to 1.8 K (-41.50 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Buy | M | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Payment of Exercise | F | 52.13 | 1,701 | 88,673 | 2,049 | 3.8 K to 2 K (-45.36 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Buy | M | 0.00 | 3,750 | 0 | 3,750 | 0 to 3.8 K |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Option Exercise | A | 52.13 | 12,000 | 625,560 | 12,000 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,700 | 0 | 11,100 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Payment of Exercise | F | 52.13 | 1,678 | 87,474 | 4,522 | 6.2 K to 4.5 K (-27.06 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Buy | M | 0.00 | 3,700 | 0 | 6,200 | 2.5 K to 6.2 K (+148.00 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | M | 0.00 | 10,950 | 0 | 32,850 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Payment of Exercise | F | 52.13 | 4,965 | 258,825 | 5,985 | 11 K to 6 K (-45.34 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Buy | M | 0.00 | 10,950 | 0 | 10,950 | 0 to 11 K |
| Dec 18 2019 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Option Exercise | M | 20.79 | 3,537 | 73,534 | 15,218 | |
| Dec 18 2019 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Sell | S | 55.13 | 3,537 | 194,985 | 0 | 3.5 K to 0 (-100.00 %) |
| Dec 18 2019 | BHVN | Biohaven Pharmaceu ... | AGUIAR ERIC | Director | Buy | M | 20.79 | 3,537 | 73,534 | 3,537 | 0 to 3.5 K |